The polymerase chain reaction evaluation of Borrelia burgdorferi DNA presence in peripheral blood of patients with Lyme disease;Ocena wystȩpowania materiału genetycznego Borrelia burgdorferi we krwi obwodowej chorych na boreliozȩ metoda̧ łaṅcuchowej reakcji polimerazowej

Polski Merkuriusz Lekarski

Volumn 17, Issue 102, 2004, Pages 593-596

  Kondrusik, Maciej ^a,b   Grygorczuk, Sambor ^a   Skotarczak, Bogumiła ^a   Wodecka, Beata ^a   Pancewicz, Sławomir ^a   Zajkowska, Joanna ^a   Swierzbińska, Renata ^a   Hermanowska Szpakowicz, Teresa ^a  

^a Kliniki Chorob Zakaznych I N ^*

^b Klinika Chorob Zakaznych I N   (Poland)

Author keywords

Borrelia burdgorferi genetic material; Borreliosis

Indexed keywords

BACTERIAL DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOAL DNA;

ARTICLE; BLOOD; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; ADOLESCENT; ADULT; AGED; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BORRELIA BURGDORFERI; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN M; LYME DISEASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 11844260652     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bunikis J., Barbour A.G.: Laboratory testing for suspected Lyme disease. Med. Clin. N. Am., 2002, 86, 2, 311-339.
2. Bunikis J., Olsen B. , Fingerle V. i wsp.: Molecular Polymorphism of the Lyme Disease Agent B. garinii in Northern Europe Is Influenced by a Novel Enzootic B. Focus in the North Atlantic. J. Clin. Microbiol., 1996, 34, 364-368.
3. Christen H.J., Eiffert H., Ohlenbusch A. i wsp.: Evaluation of polymerase chain reaction for the detection of B. burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy. Eur. J. Pediatr., 1995, 154, 374-377.
4. Goodman J.L., Bradley J.F., Ross A.E. i wsp.: Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blionded study using the polymerase chain reaction. Am. J. Med., 1995, 99, 6-12.
5. Lange R., Seyyedi S.: Evidence of a Lyme borreliosis infection from the viepoint of laboratory medicine. Int. J. Med. Microbiol., 2002, 291, suppl. 33, 120-124.
6. Lin T., Oliver J.R., Gao L. i wsp.: Genetic Heterogeneity of B. burdorferi Sensu Lato in the Southern United States Based on Restriction Fragment Length Polymorphism and Sequence Analysis. J. Clin. Microbiol., 2001, 39, 2500-2507.
7. Lebech A.M., Hansen K., Brandrup F. i wsp.: Diagnostic value of PCR for detection of B. burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol. Diagn., 2000, 5, 139-150.
8. Lebech A.M.: Polymerase chain reaction in diagnosis of B. burgdorferi infection and studies on taxonomic classification. APMIS, 2002, 105, 1-40.
9. Marconi R.T., Garon C.F.: 1992. Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J. Clin. Microbiol., 30, 11, 2830-2834.
10. Mercier G., Burckel A., Lucotte G.: Detection of B. burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions. Mol. Cell. Probes., 1997, 11, 2, 89-94.
11. Molloy P.J., Persing D.H., Berardi V.P.: False-positive resaults of PCR testing for Lyme diseases. Clin. Infect. Dis., 2001, 33, 412-413.
12. Nocton J.J., Bloom B.J., Rulledge B.J. i wsp.: Detection of B. burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J. Infect. Dis., 1996, 174, 3, 623-627.
13. Oksi J., Marttila H., Soini H. i wsp.: Early dissemination of B. burgdorferi without generalized symptoms in patients with erythema migrans. APMIS, 2001, 109, 9, 581-588.
14. Pleyer U., Priem S., Bergmann L. i wsp.: Detection of B. burgdorferi DNA in urine of patients with ocular Lyme borreliosis. Br. J. Ophtalmol., 2001, 85, 5, 552-555.
15. Priem S., Rittig M.G., Kamradt T. i wsp.: An optimized PCR leads to rapid and highly sensitive detection of B. burgdorferi in patients with Lyme disease. J. Clin. Microbiol., 1997, 35, 685-690.
16. Schmidt B. , Muellegger R.R., Stockenhuber C. i wsp.: Detection of B. burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J. Clin. Microbiol., 1996, 34, 6, 1359-1363.
17. Schwartz I., Wormser G.P., Schwartz J.J. i wsp.: Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J. Clin. Microbiol., 1992, 30, 3082-3088.
18. Skotarczak B., Wodecka B., Hermanowska-Szpakowicz T.: 2002. Czułość techniki PCR w wykrywaniu DNA B. burgdorferi sensu lato w różnych ízolatach. Przegl. Epidem., 56, suppl. 1, 73-79.
19. Tylewska-Wierzbanowska S., Chmielewski T.: Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods.
20. Stańczak J., Picken R.N., Wegner Z. i wsp.: 1996. Comparison of immunofluorescence assay and culture isolation for the detection of B. burgdorferi sensu lato in Ixodes ricinus from northern Poland - VII International Congress on Lyme Borreliosis. San Francisco. California. June 16-21, 1996.
21. Zore A., Ruzic-Sabljis E., Maraspin V. i wsp.: Sensivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien. Klin. Wochenschr., 2002, 114, 13-14, 606-609.